The Institutional Review Board (IRB) is responsible for assuring the ethical protection of the rights and welfare of human subjects from research risks. The IRB assures that all human research conducted under the auspices of QBRI are ethically and methodologically sound as required under public law and, most importantly, as expected by the public trust. The IRB is a highly professional committee that reviews and approves human research protocols of various disciplines and all related processes and documents to ensure that the rights and welfare of human subjects are protected above all other considerations. The IRB has the authority to approve, require modifications, or disapprove all research activities that fall within their jurisdiction in conformity with all ethical foundations for the Protection of human subjects. The IRB functions independently, so as to protect its ethical mission without compromise and without any perception of conflict of interest or undue influence of power. QBRI Institutional Review Board has the Supreme Council of Health
assurance, and the Wide Federal Assurance (WFA) of the Office for Human Research Protections (OHRP) of the US Department of Health and Human Services (DHHS), to comply with Qatari regulations concerning research involving human subjects, including the ethical principles outlined in the Belmont Report and the DHHS regulations 45 CFR Part 46.
IRB members include physicians, ethicists, psychologists, and individuals with expertise in allied disciplines.
More specifically, the QBRI Institutional Review Board is committed to the following ethical requirements:
Download IRB application forms
- Social Value
- Scientific Merit
- Respect for Persons
- Respect for Vulnerable Persons
- Privacy and Confidentiality
- Collaborative Partnerships
- Ethical Review
- Professional Competence
Institutional Biosafety Committee (IBC) is the cornerstone of institutional oversight of biomedical, to recombinant DNA & genetically modified organisms research programs. QBRI IBC program is approved by Supreme Council of Health
and it consists of three constituent elements:
- Biological Risk Assessment
- identification of each laboratory biosafety level criteria
- biosecurity - the management of risks associated with facilities and operations
- vivarium research facility safety
- Occupational health and immunoprophylaxis plans
- Emergency planning
The aim of IBC is to review and approve recombinant DNA research proposals conducted at or sponsored by the QBRI for compliance with the International Biosafety Guidelines and tailoring biosafety programs as per the level of risk assessed, monitor transactions by requiring annual reports and carry out the inspection of institutional facilities, maintain a register of approved projects that periodically reviewed to ensure compliance at the containment facilities (laboratories, animal houses), including personnel working on genetic manipulation in facilities, ensure all persons dealing with GMOs are adequately trained and that a record of trained personnel is maintained. Adopting emergency plans covering accidental spills and personnel contamination resulting from recombinant DNA research is one of the most important roles of the IBC.
The Institutional Biosafety Committee is comprised of selected professionals in biosafety & medical research, have experience and expertise in recombinant DNA technology and the capability to assess the safety of recombinant DNA research and to identify any potential risk to public health or the environment and QBRI Biosafety officer.